临床trials are more complex and require greater laboratory expertise than ever before. To support your drug development challenges, our scientists bring experience that spans translational biomarker development, flow cytometry, anatomic pathology and histology, vaccines, immunology, and multiple other disciplines.
指导你的决策从发现到clinic with exploratory biomarker insights from Covance Translational Biomarker Solutions (TBS). From initial feasibility and development to advanced validation, testing and production, the experienced TBS team offers collaborative support and fit-for-purpose assays using a diverse toolbox of platforms. Personalized生物标志物support is also available to help drive your development from bench to commercialization.
Quality laboratory management made easy. ELMS manages third-party laboratory performance with a rigorous identification, qualification, monitoring and reporting plan to ensure high quality and actionable data. The ELMS team will also support esoteric testing through LabCorp’s Specialty Testing Group, a distinctive combination of specialty laboratories offering discrete esoteric testing capabilities and expertise.
APH laboratories located strategically around the world—many co-located within our global network of central labs—employ innovative technologies, such as digital pathology or multiplex IHC to unlock and analyze scientific insights.
测量和遵循尿液，血清或等离子体中的生物标志物，激素，特异性抗体或病毒标志物，以获得对治疗性干预的患者反应的见解。Covance提供专门的，专用的疫苗团队和专门构建的疫苗和新型免疫治疗实验室，以提供对疫苗开发的支持 - 从生物标志物发现和测定开发到季节性或多年全球研究中的临床测试。